has been cited by the following article(s):
[1]
|
Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases
|
|
Phytomedicine Plus,
2024 |
|
|
[2]
|
In Silico Evaluation of the Potential Interference of Boceprevir, Calpain Inhibitor II, Calpain Inhibitor XII, and GC376 in the Binding of SARS-CoV-2 Spike …
|
|
Open Journal of …,
2023 |
|
|
[3]
|
An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2
|
|
Biomolecules,
2023 |
|
|
[4]
|
The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
|
|
Molecules,
2022 |
|
|
[5]
|
Plant-Derived Metabolites as Potent Inhibitor and Treatment for COVID-19
|
|
Journal of …,
2022 |
|
|
[6]
|
Évaluation du pouvoir inhibiteur des substances végétales vis-à-vis le virus de COVID 19 par Docking moléculaire: une revue systématique
|
|
Doctoral dissertation,
2021 |
|
|
[7]
|
Naringenin as a possible candidate against SARS-CoV-2 infection and in the pathogenesis of COVID-19
|
|
Natural Product …,
2021 |
|
|
[8]
|
Antiviral Activities of Naringenin and Its Derivatives as Adjuvant Treatment against SARS-CoV-2 Infections
|
|
|
|
|
[1]
|
Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases
Phytomedicine Plus,
2024
DOI:10.1016/j.phyplu.2024.100558
|
|
|
[2]
|
Antiviral activity of natural compounds extracted from Mediterranean medicinal plants against SARS-CoV-2
Academia Biology,
2024
DOI:10.20935/AcadBiol7297
|
|
|
[3]
|
An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2
Biomolecules,
2023
DOI:10.3390/biom14010043
|
|
|
[4]
|
The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
Molecules,
2022
DOI:10.3390/molecules27248938
|
|
|
[5]
|
The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
Molecules,
2022
DOI:10.3390/molecules27248938
|
|
|